SYRS
Syros Pharmaceuticals, Inc. · Healthcare
Director Srinivas Akkaraju bought $992K of Syros Pharmaceuticals, Inc.
Bought$991,558
$9.03Price
109,774Shares
+15%Stake
What SYRS did for a copier
Prices for SYRS after this filing aren't in yet.
Srinivas Akkaraju's record
15 other buys with 3 months of prices since 2017: on average +104.5% against the S&P 500, and 8 of 15 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Dec 12. Filed Thu, Dec 14, 3:22 PM ET, during the session. Not investment advice.